Teva-KOWA to buy private generics firm
This article was originally published in Scrip
Executive Summary
Teva Pharmaceutical and KOWA's joint venture Teva-KOWA Pharma is to acquire a majority share in the private Japanese generics firm Taisho Pharmaceutical.